These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31569615)

  • 101. The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review.
    Boons CC; VAN Tulder MW; Burgers JA; Beckeringh JJ; Wagner C; Hugtenburg JG
    Anticancer Res; 2013 Sep; 33(9):3553-61. PubMed ID: 24023280
    [TBL] [Abstract][Full Text] [Related]  

  • 102. In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes.
    Papazoglou ED; Jagirdar RM; Kouliou OA; Pitaraki E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569615
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Effects of pharmacological primary cilium disturbance in the context of in vitro 2D and 3D malignant pleura mesothelioma.
    Jagirdar RM; Pitaraki E; Kotsiou OS; Rouka E; Sinis SI; Varsamas C; Marnas P; Stergiopoulou E; Giannou A; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Biochem Biophys Res Commun; 2023 Apr; 654():128-135. PubMed ID: 36907140
    [TBL] [Abstract][Full Text] [Related]  

  • 104. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.
    Onen HI; Yilmaz A; Alp E; Celik A; Demiroz SM; Konac E; Kurul IC; Menevse ES
    Hum Exp Toxicol; 2015 Feb; 34(2):117-26. PubMed ID: 25028262
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Cell and extracellular matrix interaction models in benign mesothelial and malignant pleural mesothelioma cells in 2D and 3D in-vitro.
    Jagirdar RM; Papazoglou ED; Pitaraki E; Kouliou OA; Rouka E; Giannakou L; Giannopoulos S; Sinis SI; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):543-552. PubMed ID: 33336399
    [TBL] [Abstract][Full Text] [Related]  

  • 106. 2-Deoxy-glucose Enhances the Effect of Cisplatin and Pemetrexed in Reducing Malignant Pleural Mesothelioma Cell Proliferation But Not Spheroid Growth.
    Gerogianni I; Pitaraki E; Jagirdar RM; Kouliou O; Giannakou L; Giannopoulos S; Papazoglou E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Anticancer Res; 2019 Jul; 39(7):3809-3814. PubMed ID: 31262908
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma.
    Laszlo V; Valko Z; Ozsvar J; Kovacs I; Garay T; Hoda MA; Klikovits T; Stockhammer P; Aigner C; Gröger M; Klepetko W; Berger W; Grusch M; Tovari J; Waizenegger IC; Dome B; Hegedus B
    J Mol Med (Berl); 2019 Feb; 97(2):231-242. PubMed ID: 30539198
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Modeling Epidermal Growth Factor Inhibitor-mediated Enhancement of Photodynamic Therapy Efficacy Using 3D Mesothelioma Cell Culture.
    Cramer G; Shin M; Hagan S; Katz SI; Simone CB; Busch TM; Cengel KA
    Photochem Photobiol; 2019 Jan; 95(1):397-405. PubMed ID: 30499112
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo.
    Li C; Rezov V; Joensuu E; Vartiainen V; Rönty M; Yin M; Myllärniemi M; Koli K
    Sci Rep; 2018 Jul; 8(1):10070. PubMed ID: 29968778
    [TBL] [Abstract][Full Text] [Related]  

  • 110. New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.
    Rossini M; Rizzo P; Bononi I; Clementz A; Ferrari R; Martini F; Tognon MG
    Front Oncol; 2018; 8():91. PubMed ID: 29666782
    [TBL] [Abstract][Full Text] [Related]  

  • 111. In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening.
    Mazzocchi AR; Rajan SAP; Votanopoulos KI; Hall AR; Skardal A
    Sci Rep; 2018 Feb; 8(1):2886. PubMed ID: 29440675
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.
    Senthebane DA; Rowe A; Thomford NE; Shipanga H; Munro D; Mazeedi MAMA; Almazyadi HAM; Kallmeyer K; Dandara C; Pepper MS; Parker MI; Dzobo K
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28754000
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
    Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
    Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cells.
    Hoshiba T; Tanaka M
    Biochim Biophys Acta; 2016 Nov; 1863(11):2749-2757. PubMed ID: 27558478
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Influence of AQP1 on cell adhesion, migration, and tumor sphere formation in malignant pleural mesothelioma is substratum- and histological-type dependent.
    Jagirdar RM; Apostolidou E; Molyvdas PA; Gourgoulianis KI; Hatzoglou C; Zarogiannis SG
    Am J Physiol Lung Cell Mol Physiol; 2016 Mar; 310(6):L489-95. PubMed ID: 26773069
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Baas P; Fennell D; Kerr KM; Van Schil PE; Haas RL; Peters S;
    Ann Oncol; 2015 Sep; 26 Suppl 5():v31-9. PubMed ID: 26223247
    [No Abstract]   [Full Text] [Related]  

  • 117. Survival from malignant mesothelioma: where are we now?
    Marshall AD; Bayes HK; Bardgett J; Wedderburn S; Kerr KM; Currie GP
    J R Coll Physicians Edinb; 2015; 45(2):123-6. PubMed ID: 26181527
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Pleural mesothelial cells in pleural and lung diseases.
    Batra H; Antony VB
    J Thorac Dis; 2015 Jun; 7(6):964-80. PubMed ID: 26150910
    [TBL] [Abstract][Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.